Healthcare Distribution Alliance – Patients Move Us.
Share Print


HDMA Commends House Energy and Commerce Health Subcommittee Passage of Legislation to Address U.S. Prescription Drug Epidemic

May 28, 2014

ARLINGTON, Va. — HDMA President and CEO John M. Gray released the following statement on today's passage of the Ensuring Patient Access and Effective Drug Enforcement Act of 2014 (H.R. 4709) by the House Energy and Commerce Subcommittee on Health. The legislation is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)

“Prescription drug abuse is a serious and complex public health challenge, and we applaud the House Energy and Commerce Health Subcommittee for passing this important legislation. The addition of Democratic co-sponsors Reps. Welch and Chu highlights that this public health crisis requires a bipartisan effort, to ensure legitimate patients are able to access the medicines they need, while providing the clarity needed to combat the inappropriate use of these products.

“Similar to the way drug manufacturers interact with the Food and Drug Administration, the legislation will help curtail unnecessary supply chain disruptions that affect patient access to needed medications by allowing companies registered with the Drug Enforcement Administration (DEA) to submit corrective action plans to address DEA concerns. Doing so will create a more robust and transparent process to address drug diversion. Additionally, the clarification of key terminology in the Controlled Substances Act will help ensure that registrants have a better understanding of their responsibilities under the law.

“While this is just one component of the fight against prescription drug abuse, this legislation will go a long way in encouraging meaningful dialogue and collaboration between supply chain stakeholders and federal regulators. HDMA will continue to work with Reps. Marino, Blackburn, Welch and Chu as the legislation moves through the House.”


HDA is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. Each business day, HDA member companies ensure that over 15 million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.


Website design and development by, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | O365